CD8A and neoplasm: Interference with CHOL esterification using the steroid O-acyltransferase 1 inhibitor avasimibe increased the CHOL proportion in the plasma membrane of CD8 + tumor-infiltrating lymphocytes and improved effector T-cell function and proliferation [36, 37].